Page last updated: 2024-09-05

sb 203580 and Lymphoma, Follicular

sb 203580 has been researched along with Lymphoma, Follicular in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbott, RT; Bohling, SD; Buckstein, R; Coupland, RW; Dube, ID; Elenitoba-Johnson, KS; Jenson, SD; Lim, MS; Lin, Z; Palais, RA; Perez-Ordonez, B; Perkins, SL; Shami, PJ; Tripp, S; Wang, LY	1
Crockett, DK; Elenitoba-Johnson, KS; Jenson, SD; Lim, MS; Lin, Z	1

Other Studies

2 other study(ies) available for sb 203580 and Lymphoma, Follicular

Article	Year
Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proceedings of the National Academy of Sciences of the United States of America, 2003, Jun-10, Volume: 100, Issue:12 Topics: Apoptosis; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Enzyme Inhibitors; Gene Expression Profiling; Humans; Imidazoles; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Oligonucleotide Array Sequence Analysis; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Cytokine; Receptors, Growth Factor; Translocation, Genetic; Tumor Cells, Cultured	2003
Quantitative proteomic and transcriptional analysis of the response to the p38 mitogen-activated protein kinase inhibitor SB203580 in transformed follicular lymphoma cells. Molecular & cellular proteomics : MCP, 2004, Volume: 3, Issue:8 Topics: Cell Line, Transformed; Cell Survival; Down-Regulation; Enzyme Inhibitors; Gene Expression Profiling; Humans; Imidazoles; Lymphoma, Follicular; MAP Kinase Signaling System; Oligonucleotide Array Sequence Analysis; p38 Mitogen-Activated Protein Kinases; Proteome; Pyridines; Transcription, Genetic; Up-Regulation	2004

Article

Year

Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy.

Proceedings of the National Academy of Sciences of the United States of America, 2003, Jun-10, Volume: 100, Issue:12

Topics: Apoptosis; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Enzyme Inhibitors; Gene Expression Profiling; Humans; Imidazoles; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Oligonucleotide Array Sequence Analysis; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Cytokine; Receptors, Growth Factor; Translocation, Genetic; Tumor Cells, Cultured

2003

Quantitative proteomic and transcriptional analysis of the response to the p38 mitogen-activated protein kinase inhibitor SB203580 in transformed follicular lymphoma cells.

Molecular & cellular proteomics : MCP, 2004, Volume: 3, Issue:8

Topics: Cell Line, Transformed; Cell Survival; Down-Regulation; Enzyme Inhibitors; Gene Expression Profiling; Humans; Imidazoles; Lymphoma, Follicular; MAP Kinase Signaling System; Oligonucleotide Array Sequence Analysis; p38 Mitogen-Activated Protein Kinases; Proteome; Pyridines; Transcription, Genetic; Up-Regulation

2004